PT  - JOURNAL ARTICLE
AU  - Ribas, Antoni
AU  - Sengupta, Rajarshi
AU  - Locke, Trevan
AU  - Zaidi, Sayyed Kaleem
AU  - Campbell, Katie M.
AU  - Carethers, John M.
AU  - Jaffee, Elizabeth M.
AU  - Wherry, E. John
AU  - Soria, Jean-Charles
AU  - D'Souza, Gypsyamber
TI  - Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
AID  - 10.1158/2159-8290.CD-20-1817
DP  - 2020 Dec 19
TA  - Cancer Discovery
4099  - http://cancerdiscovery.aacrjournals.org/content/early/2021/01/04/2159-8290.CD-20-1817.short
4100  - http://cancerdiscovery.aacrjournals.org/content/early/2021/01/04/2159-8290.CD-20-1817.full
AB  - Summary: Published series on COVID-19 support the notion that patients with cancer are a particularly vulner­able population. There is a confluence of risk factors between cancer and COVID-19, and cancer care and treatments increase exposure to the virus and may dampen natural immune responses. The available evidence supports the conclusion that patients with cancer, in particular with hematologic malignancies, should be considered among the very high-risk groups for priority COVID-19 vaccination.